Related Experiment Video
Updated: Sep 28, 2026

Rapid Quantification of Oxidized and Reduced Forms of Glutathione Using Ortho -phthalaldehyde in Cultured Mammalian Cells In Vitro
Published on: June 28, 2024
Relationship between intracellular glutathione level and the mode of cell death induced by pingyangmycin
Kuo-Wei Tai1, Chong-Kuei Lii, Ming-Yung Chou
1Department of Oral and Maxillofacial Surgery, Chung Shan Medical and Dental College Hospital, Taichung, Taiwan.
Abstract:
The effects of intracellular glutathione (GSH) concentration on the toxicity of pingyangmycin in human squamous cell carcinoma cell line were evaluated. By using the GSH synthesis inhibitor D,L-buthionine-S,R-sulfoximine and the precursor of cysteine 2-oxothiazolidine-4-carboxylate (OTZ), intracellular glutathione levels were artificially changed. After exposed to different GSH concentrations cultured tumor cells were treated with pingyangmycin and the resultant mode of cell death was analyzed using morphological and biochemical criteria. It was found that the toxicity of pingyangmycin was obviously increased to cultured tumor cells on lowering GSH levels, with the mode of cell death switching from necrosis to apoptosis. In contract, treatment with OTZ increased GSH level compared with that of control cells, inhibited cell death induced by pingyangmycin via a necrotic rather than apoptotic process. These observations suggest that modulation of GSH levels effects the toxicity of pingyangmycin and that GSH influences the mode of cell death induced by pingyangmycin.
Insights
Lowering intracellular glutathione (GSH) levels increases pingyangmycin toxicity in cancer cells, shifting cell death from necrosis to apoptosis. Conversely, increasing GSH levels protects cells from pingyangmycin-induced death.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Intracellular glutathione (GSH) plays a crucial role in cellular defense mechanisms.
- Understanding the role of GSH in drug toxicity is vital for cancer therapy.
- Pingyangmycin is an anticancer agent whose efficacy may be modulated by cellular redox status.
Purpose of the Study:
- To investigate the impact of varying intracellular glutathione (GSH) concentrations on the toxicity of pingyangmycin.
- To determine how GSH levels influence the mode of cell death induced by pingyangmycin in human squamous cell carcinoma.
- To explore potential strategies for enhancing pingyangmycin efficacy through GSH modulation.
Main Methods:
- Artificially altering intracellular GSH levels using D,L-buthionine-S,R-sulfoximine (GSH synthesis inhibitor) and 2-oxothiazolidine-4-carboxylate (OTZ, cysteine precursor).
- Treating cultured human squamous cell carcinoma cells with pingyangmycin at different GSH concentrations.
- Analyzing the mode of cell death (necrosis vs. apoptosis) using morphological and biochemical criteria.
Main Results:
- Decreased intracellular GSH levels significantly enhanced pingyangmycin's toxicity towards tumor cells.
- Lowering GSH levels induced a switch in cell death from necrosis to apoptosis.
- Elevated GSH levels, achieved with OTZ treatment, inhibited pingyangmycin-induced cell death, favoring necrosis over apoptosis.
Conclusions:
- Intracellular glutathione (GSH) concentration critically affects pingyangmycin's toxicity in human squamous cell carcinoma.
- GSH levels play a key role in determining the mode of cell death induced by pingyangmycin.
- Modulating cellular GSH levels presents a potential strategy to optimize pingyangmycin-based cancer therapies.

